6550--Genexus Comprehensive Maintenance, Reagents & Supplies for SARS-Cov-2 & pharmocogenetic Sequencing for RMRVAMC
Contact and place of performance
Tania Urenda
HOUSTON, TX 77070
TX
Placeholder
The Department of Veterans Affairs, Network Contracting Office 19, issued a justification for a sole-source procurement under solicitation number 36C25923Q0308. This requirement provides Genexus comprehensive maintenance, reagents, and supplies necessary for SARS-CoV-2 and pharmacogenetic sequencing at the Rocky Mountain Regional VA Medical Center (RMRVAMC). The acquisition is classified under NAICS 334516, Analytical Laboratory Instrument Manufacturing, and PSC 6550, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.
The notice was published on May 23, 2023, and identifies Tania Urenda as the point of contact. Although the primary facility served is the RMRVAMC, the metadata identifies the place of performance as Houston, Texas. Related documentation for this action includes two attachments: a Word document and a signed Justification and Approval (JOFOC) document approved by the HCA.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.